Since Evotec was founded in 1993, it has participated in 14 rounds of funding. In total Evotec has raised $489.1M. Evotec's last funding round was on Mar 2025 for a total of $20.0M.
Evotec has 9 investors, including Bristol Myers Squibb, Triton Partners and The Bristol-Myers Squibb Company. The latest investment occurred in Mar 2025.
